Big Tech in Health

By Dean Koh 02:22 am June 16, 2020
Genomic medicine startup Lucence and the Agency for Science, Technology and Research (A*STAR), Singapore’s national research agency and a statutory board under the Ministry of Trade and Industry, today announced study results indicating that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection. The development of the SAFER...
By Dave Muoio and Laura Lovett 03:27 pm June 5, 2020
The deaths of George Floyd, Breonna Taylor, Ahmaud Arbery and others have lit a powder keg in the U.S. and abroad, leading to nearly two weeks of protests and demonstrations that highlight the pervasive and long-standing issues of racism, racial inequality and police brutality.  As public pressure mounts on those in positions to create change, a number of technology and health organizations have...
By Laura Lovett 03:43 pm May 27, 2020
For quite a while now, tech titans Facebook, Amazon, Microsoft, Google and Apple have been quickly gaining prominence in the healthcare industry. In a new report, CB Insights dives into what each of the companies are up to and possible next moves.  First, Facebook, the report shines light on the fact that it has the ability to look at huge swaths of user data and behaviors. It also looks at how...

Credit: Infermedica

By Tammy Lovell 05:56 am May 27, 2020
Polish startup Infermedica has announced a collaboration with tech giant Microsoft, which aims to empower healthcare organisations to build and deploy virtual healthcare assistants at scale. The artificial intelligence (AI) health company, which specialises in early diagnosis and triage, announced in a blog post that it will provide its technology to the Microsoft Healthcare Bot service. By...
By Dean Koh 07:28 am April 23, 2020
Singapore-based biotech start-up MiRXES announced that it has received Provisional Authorization from the Health Sciences Authority (HSA) Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR (reverse transcriptase polymerase chain reaction) test. With technology licensed from Singapore’s Agency for Science, Technology, and Research (A*STAR) and the HSA Provisional Authorization,...
By Dean Koh 03:30 am April 16, 2020
Camtech Diagnostics, the R & D arm of Singapore-based tech company Camtech Holdings, and JN Medsys, a Singapore-based biotech company, announced plans to increase production of two COVID-19 test kits in Singapore, having obtained provisional authorization from Singapore’s Health Sciences Authority (HSA).  WHAT THE TEST KITS DO Camtech Diagnostics’ COVID-19 IgG/IgM Rapid Qualitative Screening...
By Dean Koh 05:08 am April 14, 2020
Singapore-listed medtech company Biolidics announced that it has completed the notification process for the intended distribution of its rapid test kits for COVID-19 under Section IV.D of the “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” (Policy D) of the United States of America (USA) and it has received an acknowledgement from the U.S. Food and...
By Dave Muoio 02:19 pm April 10, 2020
Two of the biggest names in technology have formed an unprecedented partnership to introduce health data-sharing and COVID-19 contact-tracing technologies to the lion's share of the smartphone market. In dual news releases published this afternoon, Apple and Google announced plans to launch APIs that will enable interoperability between iOS and Android products by way of official apps from public...
By Dave Muoio 03:13 pm April 6, 2020
Google is taking its coronavirus support efforts one step further with the launch of its COVID-19 Community Mobility Reports web tool late last week. Similar to the way Google Maps displays whether certain businesses or public places are busy at certain times of day, the resource aggregates anonymized location tracking data from mobile devices to identify large-scale behavior trends. The end...

Credit: Biolidics

By Dean Koh 03:17 am March 31, 2020
Singapore-listed medtech company Biolidics recently launched its rapid test kit for COVID-19 and has entered into a manufacturer agreement with a diagnostic kit manufacturer to customize and manufacture the rapid test kits. The first batch of Biolidics’ rapid test kits is expected to be available in April 2020. Biolidics has obtained provisional authorization from Singapore’s Health Science...